about
The Suitability of End Point Designs for Health Technology Assessment in Chronic Pain StudiesEconomic Evaluations in the Diagnosis and Management of Traumatic Brain Injury: A Systematic Review and Analysis of QualityInvestigating the Generalizability of Economic Evaluations Conducted in Italy: A Critical ReviewA Systematic Review on the Cost-Effectiveness of Genetic and Electrocardiogram Testing for Long QT Syndrome in Infants and Young AdultsSelecting a dynamic simulation modeling method for health care delivery research-part 2: report of the ISPOR Dynamic Simulation Modeling Emerging Good Practices Task ForceCost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force reportThe inclusion of informal care in applied economic evaluation: a reviewCan we use social media to support content validity of patient-reported outcome instruments in medical product development?Optimizing the leveraging of real-world data to improve the development and use of medicinesCost-effectiveness of aldosterone antagonists for the treatment of post-myocardial infarction heart failureAdding decision models to systematic reviews: informing a framework for deciding when and how to do soA systematic review of generic multidimensional patient-reported outcome measures for children, part I: descriptive characteristicsAn expert on every street corner? Methods for eliciting distributions in geographically dispersed opinion poolsUS valuation of health outcomes measured using the PROMIS-29.Bringing Patient-Centered Outcomes Research to Life.Rare Disease Terminology and Definitions-A Systematic Global Review: Report of the ISPOR Rare Disease Special Interest GroupCritical appraisal of network meta-analyses evaluating the efficacy and safety of new oral anticoagulants in atrial fibrillation stroke prevention trialsApplying dynamic simulation modeling methods in health care delivery research-the SIMULATE checklist: report of the ISPOR simulation modeling emerging good practices task forceA Systematic Review of Research Guidelines in Decision-Analytic ModelingCost-effectiveness of antiplatelet agents in secondary stroke prevention: the limits of certaintyEstimating survival for cost-effectiveness analyses: a case study in atherothrombosisAssessment of PRO label claims granted by the FDA as compared to the EMA (2006-2010)Economic Burden of Long-Term Complications of Deep Vein Thrombosis after Total Hip Replacement Surgery in the United StatesPolicies for Use of Real-World Data in Health Technology Assessment (HTA): A Comparative Study of Six HTA AgenciesValue for Money in H1N1 Influenza: A Systematic Review of the Cost-Effectiveness of Pandemic Interventions.Economic Consequences and Potentially Preventable Costs Related to Osteoporosis in the Netherlands.A Systematic Review of Health Economics Simulation Models of Chronic Obstructive Pulmonary Disease.Health State Preference Weights for the Glasgow Outcome Scale Following Traumatic Brain Injury: A Systematic Review and Mapping Study.Cost-Utility Analysis of Preventive Home Visits in Older Adults.Economic evaluation of influenza pandemic mitigation strategies in the United States using a stochastic microsimulation transmission model.Cost-Utility Analysis of Optimal Dosing of Oseltamivir Under Pandemic Influenza Using a Novel Approach: Linking Health Economics and Transmission Dynamic Models.Do Model-Based Studies in Chronic Obstructive Pulmonary Disease Measure Correct Values of Utility? A Meta-Analysis.Modeling the effects of H1N1 influenza vaccine distribution in the United States.Development of a database of instruments for resource-use measurement: purpose, feasibility, and design.Appraising The Cost Of Physician Visits And Technical Procedures In France In The Age Of Open Data.Impact of Ongoing National Health Technology Assessment Challenges on Patient Access to New Therapies for Multiple Sclerosis In Germany And The Uk.Economic evaluations of smoking cessation and relapse prevention programs for pregnant women: a systematic reviewCost-effectiveness of a computerized provider order entry system in improving medication safety ambulatory care.Conceptualizing a model: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--2.The comparison of trial data-based and registry data-based cost-effectiveness of infliximab treatment for rheumatoid arthritis in Sweden using a modeling approach.
P1433
Q26774693-ADA4D11F-2A1E-4C1B-8E61-F80C804EC09CQ26795681-5F8B02AA-954C-4E8F-81DF-C48B0D00BBDDQ26795684-1435DB3A-0435-4E83-88E3-38170BF1CE69Q26795687-96E56A4D-63D8-404B-B31F-C3927C60E8FBQ26822464-F170F38B-A68F-4C49-A407-4082A6FACE1EQ26825405-B3AFE286-7402-4327-AB62-4C5D388CFFCAQ26860893-04DA2DDA-E3BC-4379-AE72-38F83D7EAD96Q27004598-CF9B1531-A74B-4438-82BD-942E5877F000Q27008498-2508FE43-EC77-4E14-A59A-F5A5E1EE0F3AQ27011639-05FF8D3D-1322-4A4E-BC1C-4E55527CE6E0Q27013064-17887C67-7407-43B6-B26A-E6F1307B8303Q27016062-8289E5A7-2530-4531-9F94-FC59576C5366Q27026654-149B1939-99BF-4E9A-BAD9-BB808F68C255Q27308886-5D52EF96-514B-4310-85C9-FD3FCA5948A7Q27687387-09DC8D96-0FE2-4B1A-B08D-27F4481666BAQ28082148-E0D4348D-E576-4161-9F6E-E8DA1A8E5F6BQ28083560-105EC60F-FCEA-4A02-9CB9-5CE95F13D841Q28084009-CD864B27-1FD8-4BBB-A09C-53412F015727Q28084612-278735AD-01F9-4CB4-AC77-4AA5DFD23408Q28192078-A2784111-A28E-492E-9759-848672D3BCB3Q28212937-39FF823C-55DA-4227-8B5F-272DB2C53DEEQ28303721-58CA2692-E75C-481F-9682-48E7AEA8C097Q29039533-BAA5CC55-E175-4C17-A189-CA61C78E1350Q29994634-2ADCAF9C-C3A4-4862-8403-011EC1985BAFQ30234108-19A1C5AD-4608-474A-A352-D8B9A46FF5C6Q30234109-726FBE16-B333-4510-A257-9F215CB0B285Q30235885-C4D3F31E-C84A-42E4-A478-CB930B7A6639Q30235886-C89F2A38-787F-43C9-AB47-72A797C9A9D8Q30316997-F1371429-E534-4E27-AB7E-D4CF4319D401Q30371134-D05FE705-B97E-4999-843E-3443576C2043Q30388336-F74C3714-F52B-4E7D-8A37-438B70F18BCCQ30389601-C9788EFB-728D-411E-AE35-2BD56B7BFDEBQ30412069-C4991820-7DEC-40BF-90DE-E9D2AD23DA34Q30485625-E4E23244-08BA-4B1F-811D-1B1951944E56Q30488516-B35BB71D-4BCF-4FE8-BC6C-A3BB2C59EF86Q30488518-CC6F85E9-C7D4-447B-A58B-356B22DD017CQ30489771-7495BDCC-6CB0-416A-AA6F-9CC74BA66178Q30582516-A8C72562-5459-4827-A663-9EFC32EFB4A8Q30595581-B777C0E4-3506-443E-AE81-D7461CB96453Q30608529-6C531D03-FDEC-4C46-9F42-DE82F2C30B70
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift van Elsevier
@nl
wissenschaftliche Fachzeitschrift
@de
name
Value in Health
@ast
Value in Health
@da
Value in Health
@en
Value in Health
@es
Value in Health
@fi
Value in Health
@fr
Value in Health
@it
Value in Health
@nb
Value in Health
@nl
Value in Health
@nn
type
label
Value in Health
@ast
Value in Health
@da
Value in Health
@en
Value in Health
@es
Value in Health
@fi
Value in Health
@fr
Value in Health
@it
Value in Health
@nb
Value in Health
@nl
Value in Health
@nn
prefLabel
Value in Health
@ast
Value in Health
@da
Value in Health
@en
Value in Health
@es
Value in Health
@fi
Value in Health
@fr
Value in Health
@it
Value in Health
@nb
Value in Health
@nl
Value in Health
@nn
P31
P3181
P1055
P1058
P1156
P123
P1250
P1277
P1476
Value in Health
@en
P236
P407
P571
1998-01-01T00:00:00Z